JG
SAGE

Jefferies Group’s Sage Therapeutics SAGE Stock Holding History

Jefferies Group’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-9,700
Closed -$413K – 1901
2021
Q4 		$413K Buy
9,700
+9,600
+9,600% +$402K ﹤0.01% 1226
2021
Q3 		$4.43K Sell
100
-35,800
-100% -$1.64M ﹤0.01% 1663
2021
Q2 		$2.04M Sell
35,900
-20,900
-37% -$1.48M 0.01% 743
2021
Q1 		$4.25M Buy
56,800
+17,900
+46% +$1.47M 0.04% 433
2020
Q4 		$3.37M Buy
38,900
+32,200
+481% +$2.37M 0.03% 541
2020
Q3 		$410K Buy
+6,700
New +$340K ﹤0.01% 1031
2020
Q1 		– Sell
-65,400
Closed -$4.72M – 2584
2019
Q4 		$4.72M Sell
65,400
-9,700
-13% -$1.19M 0.04% 544
2019
Q3 		$10.5M Buy
75,100
+12,400
+20% +$2.07M 0.08% 209
2019
Q2 		$11.5M Sell
62,700
-21,700
-26% -$3.7M 0.08% 194
2019
Q1 		$13.4M Buy
84,400
+70,000
+486% +$10.1M 0.11% 148
2018
Q4 		$1.38M Buy
+14,400
New +$1.65M 0.01% 1005
2017
Q3 		– Sell
-27,500
Closed -$2.19M – 2579
2017
Q2 		$2.19M Buy
27,500
+26,700
+3,338% +$1.93M 0.01% 896
2017
Q1 		$57K Buy
+800
New +$46.9K ﹤0.01% 2178
2016
Q4 		– Sell
-65,900
Closed -$3.04M – 2441
2016
Q3 		$3.04M Sell
65,900
-347,600
-84% -$14.1M 0.02% 748
2016
Q2 		$12.5M Buy
+413,500
New +$13.8M 0.06% 233

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jefferies Group's SAGE Position: Q3 2022 in Review

Jefferies Group held its Sage Therapeutics (SAGE) position steady in Q3 2022 at 9,250 shares worth $362K. The position accounts for ﹤0.01% of the portfolio, ranked #1157.

Jefferies Group first reported a position in SAGE in Q2 2016 and has held it in 19 quarters since. The position peaked at $2.62M in Q1 2019. 200 funds tracked by Wall St. Rank hold SAGE as of Q3 2022.

  • Jefferies Group held 9,250 shares of Sage Therapeutics worth $362K as of Q3 2022.
  • Jefferies Group left its Sage Therapeutics share count unchanged in Q3 2022.
  • Sage Therapeutics made up ﹤0.01% of Jefferies Group's portfolio in Q3 2022, its #1157 holding.
  • Jefferies Group first reported a position in Sage Therapeutics in Q2 2016 and has held it in 19 quarters since.
  • Jefferies Group's Sage Therapeutics position peaked at $2.62M in Q1 2019.
  • 200 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.